메뉴 건너뛰기




Volumn 4, Issue 2, 2012, Pages 340-353

Remodeling of tumor stroma and response to therapy

Author keywords

Angiogenesis; Immunotherapy; Tumor microenvironment; Tumor stroma

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; COLLAGEN TYPE 4; DNA TOPOISOMERASE (ATP HYDROLYSING); ENDOTHELIN B RECEPTOR; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; IMATINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LAMININ; PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE INHIBITOR; PROTEIN ZO1; SARIDEGIB; SCATTER FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1; SUNITINIB; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

EID: 84862683653     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers4020340     Document Type: Review
Times cited : (12)

References (81)
  • 1
    • 33645739790 scopus 로고    scopus 로고
    • Tumor stroma and regulation of cancer development
    • Tlsty, T.D.; Coussens, L.M. Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 2006, 1, 119-150.
    • (2006) Annu. Rev. Pathol , vol.1 , pp. 119-150
    • Tlsty, T.D.1    Coussens, L.M.2
  • 2
    • 34547358822 scopus 로고    scopus 로고
    • Tumor stroma fosters neovascularization by recruitment of progenitor cells into the tumor bed
    • Ganss, R. Tumor stroma fosters neovascularization by recruitment of progenitor cells into the tumor bed. J. Cell. Mol. Med. 2006, 10, 857-865.
    • (2006) J. Cell. Mol. Med , vol.10 , pp. 857-865
    • Ganss, R.1
  • 6
    • 33747602354 scopus 로고    scopus 로고
    • Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis
    • Nozawa, H.; Chiu, C.; Hanahan, D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. USA 2006, 103, 12493-12498.
    • (2006) Proc. Natl. Acad. Sci. USA , vol.103 , pp. 12493-12498
    • Nozawa, H.1    Chiu, C.2    Hanahan, D.3
  • 9
    • 84255196931 scopus 로고    scopus 로고
    • Immune microenvironments in solid tumors: New targets for therapy
    • Shiao, S.L.; Ganesan, A.P.; Rugo, H.S.; Coussens, L.M. Immune microenvironments in solid tumors: New targets for therapy. Genes Dev. 2011, 25, 2559-2572.
    • (2011) Genes Dev , vol.25 , pp. 2559-2572
    • Shiao, S.L.1    Ganesan, A.P.2    Rugo, H.S.3    Coussens, L.M.4
  • 10
    • 0037967272 scopus 로고    scopus 로고
    • Tumorigenesis and the angiogenic switch
    • Bergers, G.; Benjamin, L.E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 2003, 3, 401-410.
    • (2003) Nat. Rev. Cancer , vol.3 , pp. 401-410
    • Bergers, G.1    Benjamin, L.E.2
  • 11
    • 85013312416 scopus 로고
    • Tumor angiogenesis: Therapeutic implications
    • Folkman, J. Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 1971, 285, 1182-1186.
    • (1971) N. Engl. J. Med , vol.285 , pp. 1182-1186
    • Folkman, J.1
  • 12
    • 0038745370 scopus 로고    scopus 로고
    • Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer
    • Zhang, L.; Yang, N.; Park, J.W.; Katsaros, D.; Fracchioli, S.; Cao, G.; O'Brien-Jenkins, A.; Randall, T.C.; Rubin, S.C.; Coukos, G. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res. 2003, 63, 3403-3412.
    • (2003) Cancer Res , vol.63 , pp. 3403-3412
    • Zhang, L.1    Yang, N.2    Park, J.W.3    Katsaros, D.4    Fracchioli, S.5    Cao, G.6    O'brien-Jenkins, A.7    Randall, T.C.8    Rubin, S.C.9    Coukos, G.10
  • 13
    • 0033693293 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha → hypoxia response element → VEGF cascade differentially regulates vascular response and growth rate in tumors
    • Tsuzuki, Y.; Fukumura, D.; Oosthuyse, B.; Koike, C.; Carmeliet, P.; Jain, R.K. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha → hypoxia response element → VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res. 2000, 60, 6248-6252.
    • (2000) Cancer Res , vol.60 , pp. 6248-6252
    • Tsuzuki, Y.1    Fukumura, D.2    Oosthuyse, B.3    Koike, C.4    Carmeliet, P.5    Jain, R.K.6
  • 14
    • 0021111648 scopus 로고
    • Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
    • Senger, D.R.; Galli, S.J.; Dvorak, A.M.; Perruzzi, C.A.; Harvey, V.S.; Dvorak, H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219, 983-985.
    • (1983) Science , vol.219 , pp. 983-985
    • Senger, D.R.1    Galli, S.J.2    Dvorak, A.M.3    Perruzzi, C.A.4    Harvey, V.S.5    Dvorak, H.F.6
  • 15
    • 0024818355 scopus 로고
    • Vascular endothelial growth factor is a secreted angiogenic mitogen
    • Leung, D.W.; Cachianes, G.; Kuang, W.J.; Goeddel, D.V.; Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246, 1306-1309.
    • (1989) Science , vol.246 , pp. 1306-1309
    • Leung, D.W.1    Cachianes, G.2    Kuang, W.J.3    Goeddel, D.V.4    Ferrara, N.5
  • 16
    • 4944266313 scopus 로고    scopus 로고
    • High interstitial fluid pressure-An obstacle in cancer therapy
    • Heldin, C.H.; Rubin, K.; Pietras, K.; Ostman, A. High interstitial fluid pressure-An obstacle in cancer therapy. Nat. Rev. Cancer 2004, 4, 806-813.
    • (2004) Nat. Rev. Cancer , vol.4 , pp. 806-813
    • Heldin, C.H.1    Rubin, K.2    Pietras, K.3    Ostman, A.4
  • 18
    • 11844254414 scopus 로고    scopus 로고
    • Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
    • Jain, R.K. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 2005, 307, 58-62.
    • (2005) Science , vol.307 , pp. 58-62
    • Jain, R.K.1
  • 19
    • 58349108702 scopus 로고    scopus 로고
    • Modulation of G protein signaling normalizes tumor vessels
    • Manzur, M.; Hamzah, J.; Ganss, R. Modulation of G protein signaling normalizes tumor vessels. Cancer Res. 2009, 69, 396-399.
    • (2009) Cancer Res , vol.69 , pp. 396-399
    • Manzur, M.1    Hamzah, J.2    Ganss, R.3
  • 20
    • 79957894276 scopus 로고    scopus 로고
    • Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
    • Carmeliet, P.; Jain, R.K. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat. Rev. Drug Discov. 2011, 10, 417-427.
    • (2011) Nat. Rev. Drug Discov , vol.10 , pp. 417-427
    • Carmeliet, P.1    Jain, R.K.2
  • 23
    • 60649087564 scopus 로고    scopus 로고
    • Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis
    • Ebos, J.M.; Lee, C.R.; Cruz-Munoz, W.; Bjarnason, G.A.; Christensen, J.G.; Kerbel, R.S. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009, 15, 232-239.
    • (2009) Cancer Cell , vol.15 , pp. 232-239
    • Ebos, J.M.1    Lee, C.R.2    Cruz-Munoz, W.3    Bjarnason, G.A.4    Christensen, J.G.5    Kerbel, R.S.6
  • 24
    • 47949099628 scopus 로고    scopus 로고
    • Modes of resistance to anti-angiogenic therapy
    • Bergers, G.; Hanahan, D. Modes of resistance to anti-angiogenic therapy. Nat. Rev. Cancer 2008, 8, 592-603.
    • (2008) Nat. Rev. Cancer , vol.8 , pp. 592-603
    • Bergers, G.1    Hanahan, D.2
  • 25
    • 0015493534 scopus 로고
    • Metastases and the normalization of tumour blood vessels by ICRF 159: A new type of drug action
    • Le Serve, A.W.; Hellmann, K. Metastases and the normalization of tumour blood vessels by ICRF 159: A new type of drug action. Br. Med. J. 1972, 1, 597-601.
    • (1972) Br. Med. J , vol.1 , pp. 597-601
    • Le Serve, A.W.1    Hellmann, K.2
  • 26
    • 0029949160 scopus 로고    scopus 로고
    • Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
    • Yuan, F.; Chen, Y.; Dellian, M.; Safabakhsh, N.; Ferrara, N.; Jain, R.K. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. USA 1996, 93, 14765-14770.
    • (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 14765-14770
    • Yuan, F.1    Chen, Y.2    Dellian, M.3    Safabakhsh, N.4    Ferrara, N.5    Jain, R.K.6
  • 27
    • 0034796595 scopus 로고    scopus 로고
    • Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
    • Jain, R.K. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy. Nat. Med. 2001, 7, 987-989.
    • (2001) Nat. Med , vol.7 , pp. 987-989
    • Jain, R.K.1
  • 28
    • 19944422751 scopus 로고    scopus 로고
    • Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases
    • Winkler, F.; Kozin, S.V.; Tong, R.T.; Chae, S.S.; Booth, M.F.; Garkavtsev, I.; Xu, L.; Hicklin, D.J.; Fukumura, D.; di Tomaso, E. et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 2004, 6, 553-563.
    • (2004) Cancer Cell , vol.6 , pp. 553-563
    • Winkler, F.1    Kozin, S.V.2    Tong, R.T.3    Chae, S.S.4    Booth, M.F.5    Garkavtsev, I.6    Xu, L.7    Hicklin, D.J.8    Fukumura, D.9    di Tomaso, E.10
  • 29
    • 2542628099 scopus 로고    scopus 로고
    • Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors
    • Tong, R.T.; Boucher, Y.; Kozin, S.V.; Winkler, F.; Hicklin, D.J.; Jain, R.K. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res. 2004, 64, 3731-3736.
    • (2004) Cancer Res , vol.64 , pp. 3731-3736
    • Tong, R.T.1    Boucher, Y.2    Kozin, S.V.3    Winkler, F.4    Hicklin, D.J.5    Jain, R.K.6
  • 32
    • 0036494443 scopus 로고    scopus 로고
    • Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication
    • Ganss, R.; Ryschich, E.; Klar, E.; Arnold, B.; Hammerling, G.J. Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication. Cancer Res. 2002, 62, 1462-1470.
    • (2002) Cancer Res , vol.62 , pp. 1462-1470
    • Ganss, R.1    Ryschich, E.2    Klar, E.3    Arnold, B.4    Hammerling, G.J.5
  • 33
    • 80054875641 scopus 로고    scopus 로고
    • Novel cancer immunotherapy agents with survival benefit: Recent successes and next steps
    • Sharma, P.; Wagner, K.; Wolchok, J.D.; Allison, J.P. Novel cancer immunotherapy agents with survival benefit: Recent successes and next steps. Nat. Rev. Cancer 2011, 11, 805-812.
    • (2011) Nat. Rev. Cancer , vol.11 , pp. 805-812
    • Sharma, P.1    Wagner, K.2    Wolchok, J.D.3    Allison, J.P.4
  • 34
    • 7244260416 scopus 로고    scopus 로고
    • Mini-review: Overcoming tumor-intrinsic resistance to immune effector function
    • Ganss, R.; Arnold, B.; Hammerling, G.J. Mini-review: Overcoming tumor-intrinsic resistance to immune effector function. Eur. J. Immunol. 2004, 34, 2635-2641.
    • (2004) Eur. J. Immunol , vol.34 , pp. 2635-2641
    • Ganss, R.1    Arnold, B.2    Hammerling, G.J.3
  • 35
    • 2442452552 scopus 로고    scopus 로고
    • CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction
    • Garbi, N.; Arnold, B.; Gordon, S.; Hammerling, G.J.; Ganss, R. CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction. J. Immunol. 2004, 172, 5861-5869.
    • (2004) J. Immunol , vol.172 , pp. 5861-5869
    • Garbi, N.1    Arnold, B.2    Gordon, S.3    Hammerling, G.J.4    Ganss, R.5
  • 36
    • 48149105835 scopus 로고    scopus 로고
    • Anti-angiogenesis: Making the tumor vulnerable to the immune system
    • Griffioen, A.W. Anti-angiogenesis: Making the tumor vulnerable to the immune system. Cancer Immunol. Immunother. 2008, 57, 1553-1558.
    • (2008) Cancer Immunol. Immunother , vol.57 , pp. 1553-1558
    • Griffioen, A.W.1
  • 39
    • 79959944026 scopus 로고    scopus 로고
    • Antiangiogenic therapy, hypoxia, and metastasis: Risky liaisons, or not
    • de Bock, K.; Mazzone, M.; Carmeliet, P. Antiangiogenic therapy, hypoxia, and metastasis: Risky liaisons, or not? Nat. Rev. Clin. Oncol. 2011, 8, 393-404.
    • (2011) Nat. Rev. Clin. Oncol , vol.8 , pp. 393-404
    • de Bock, K.1    Mazzone, M.2    Carmeliet, P.3
  • 41
    • 0036124520 scopus 로고    scopus 로고
    • Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors
    • Morikawa, S.; Baluk, P.; Kaidoh, T.; Haskell, A.; Jain, R.K.; McDonald, D.M. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 2002, 160, 985-1000.
    • (2002) Am. J. Pathol , vol.160 , pp. 985-1000
    • Morikawa, S.1    Baluk, P.2    Kaidoh, T.3    Haskell, A.4    Jain, R.K.5    McDonald, D.M.6
  • 42
    • 26944437515 scopus 로고    scopus 로고
    • + perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival
    • + perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat. Cell Biol. 2005, 7, 870-879.
    • (2005) Nat. Cell Biol , vol.7 , pp. 870-879
    • Song, S.1    Ewald, A.J.2    Stallcup, W.3    Werb, Z.4    Bergers, G.5
  • 43
    • 12844255716 scopus 로고    scopus 로고
    • Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization
    • Berger, M.; Bergers, G.; Arnold, B.; Hammerling, G.J.; Ganss, R. Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood 2005, 105, 1094-1101.
    • (2005) Blood , vol.105 , pp. 1094-1101
    • Berger, M.1    Bergers, G.2    Arnold, B.3    Hammerling, G.J.4    Ganss, R.5
  • 44
    • 49749149560 scopus 로고    scopus 로고
    • Modulation of the "blood-tumor" barrier improves immunotherapy
    • Manzur, M.; Hamzah, J.; Ganss, R. Modulation of the "blood-tumor" barrier improves immunotherapy. Cell Cycle 2008, 7, 2452-2455.
    • (2008) Cell Cycle , vol.7 , pp. 2452-2455
    • Manzur, M.1    Hamzah, J.2    Ganss, R.3
  • 45
    • 77955406159 scopus 로고    scopus 로고
    • Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer
    • Shrimali, R.K.; Yu, Z.; Theoret, M.R.; Chinnasamy, D.; Restifo, N.P.; Rosenberg, S.A. Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer. Cancer Res. 2010, 70, 6171-6180.
    • (2010) Cancer Res , vol.70 , pp. 6171-6180
    • Shrimali, R.K.1    Yu, Z.2    Theoret, M.R.3    Chinnasamy, D.4    Restifo, N.P.5    Rosenberg, S.A.6
  • 46
    • 43049147611 scopus 로고    scopus 로고
    • Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in mice
    • Hamzah, J.; Nelson, D.; Moldenhauer, G.; Arnold, B.; Hammerling, G.J.; Ganss, R. Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in mice. J. Clin. Invest. 2008, 118, 1691-1699.
    • (2008) J. Clin. Invest , vol.118 , pp. 1691-1699
    • Hamzah, J.1    Nelson, D.2    Moldenhauer, G.3    Arnold, B.4    Hammerling, G.J.5    Ganss, R.6
  • 48
    • 78651461701 scopus 로고    scopus 로고
    • HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF
    • Rolny, C.; Mazzone, M.; Tugues, S.; Laoui, D.; Johansson, I.; Coulon, C.; Squadrito, M.L.; Segura, I.; Li, X.; Knevels, E. et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 2011, 19, 31-44.
    • (2011) Cancer Cell , vol.19 , pp. 31-44
    • Rolny, C.1    Mazzone, M.2    Tugues, S.3    Laoui, D.4    Johansson, I.5    Coulon, C.6    Squadrito, M.L.7    Segura, I.8    Li, X.9    Knevels, E.10
  • 49
    • 25444491756 scopus 로고    scopus 로고
    • Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients
    • Yonenaga, Y.; Mori, A.; Onodera, H.; Yasuda, S.; Oe, H.; Fujimoto, A.; Tachibana, T.; Imamura, M. Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients. Oncology 2005, 69, 159-166.
    • (2005) Oncology , vol.69 , pp. 159-166
    • Yonenaga, Y.1    Mori, A.2    Onodera, H.3    Yasuda, S.4    Oe, H.5    Fujimoto, A.6    Tachibana, T.7    Imamura, M.8
  • 50
    • 47549086341 scopus 로고    scopus 로고
    • Investigation of pericytes, hypoxia, and vascularity in bladder tumors: Association with clinical outcomes
    • O'Keeffe, M.B.; Devlin, A.H.; Burns, A.J.; Gardiner, T.A.; Logan, I.D.; Hirst, D.G.; McKeown, S.R. Investigation of pericytes, hypoxia, and vascularity in bladder tumors: Association with clinical outcomes. Oncol. Res. 2008, 17, 93-101.
    • (2008) Oncol. Res , vol.17 , pp. 93-101
    • O'Keeffe, M.B.1    Devlin, A.H.2    Burns, A.J.3    Gardiner, T.A.4    Logan, I.D.5    Hirst, D.G.6    McKeown, S.R.7
  • 51
    • 33645519235 scopus 로고    scopus 로고
    • Vascular proliferation is important for clinical progress of endometrial cancer
    • Stefansson, I.M.; Salvesen, H.B.; Akslen, L.A. Vascular proliferation is important for clinical progress of endometrial cancer. Cancer Res. 2006, 66, 3303-3309.
    • (2006) Cancer Res , vol.66 , pp. 3303-3309
    • Stefansson, I.M.1    Salvesen, H.B.2    Akslen, L.A.3
  • 52
    • 84855912001 scopus 로고    scopus 로고
    • Pericyte Depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by Met signaling pathway
    • Cooke, V.G.; Lebleu, V.S.; Keskin, D.; Khan, Z.; O'Connell, J.T.; Teng, Y.; Duncan, M.B.; Xie, L.; Maeda, G.; Vong, S. et al. Pericyte Depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by Met signaling pathway. Cancer Cell 2012, 21, 66-81.
    • (2012) Cancer Cell , vol.21 , pp. 66-81
    • Cooke, V.G.1    Lebleu, V.S.2    Keskin, D.3    Khan, Z.4    O'Connell, J.T.5    Teng, Y.6    Duncan, M.B.7    Xie, L.8    Maeda, G.9    Vong, S.10
  • 53
    • 0038476608 scopus 로고    scopus 로고
    • Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
    • Bergers, G.; Song, S.; Meyer-Morse, N.; Bergsland, E.; Hanahan, D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 2003, 111, 1287-1295.
    • (2003) J. Clin. Invest , vol.111 , pp. 1287-1295
    • Bergers, G.1    Song, S.2    Meyer-Morse, N.3    Bergsland, E.4    Hanahan, D.5
  • 54
    • 77949494504 scopus 로고    scopus 로고
    • Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma
    • Helfrich, I.; Scheffrahn, I.; Bartling, S.; Weis, J.; von Felbert, V.; Middleton, M.; Kato, M.; Ergun, S.; Schadendorf, D. Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma. J. Exp. Med. 2010, 207, 491-503.
    • (2010) J. Exp. Med , vol.207 , pp. 491-503
    • Helfrich, I.1    Scheffrahn, I.2    Bartling, S.3    Weis, J.4    von Felbert, V.5    Middleton, M.6    Kato, M.7    Ergun, S.8    Schadendorf, D.9
  • 55
    • 80052667572 scopus 로고    scopus 로고
    • Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression
    • Franco, M.; Roswall, P.; Cortez, E.; Hanahan, D.; Pietras, K. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression. Blood 2011, 118, 2906-2917.
    • (2011) Blood , vol.118 , pp. 2906-2917
    • Franco, M.1    Roswall, P.2    Cortez, E.3    Hanahan, D.4    Pietras, K.5
  • 56
    • 77953802129 scopus 로고    scopus 로고
    • The absence of pericytes does not increase the sensitivity of tumor vasculature to vascular endothelial growth factor-A blockade
    • Nisancioglu, M.H.; Betsholtz, C.; Genove, G. The absence of pericytes does not increase the sensitivity of tumor vasculature to vascular endothelial growth factor-A blockade. Cancer Res. 2010, 70, 5109-5115.
    • (2010) Cancer Res , vol.70 , pp. 5109-5115
    • Nisancioglu, M.H.1    Betsholtz, C.2    Genove, G.3
  • 57
    • 0035911221 scopus 로고    scopus 로고
    • Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
    • Lin, E.Y.; Nguyen, A.V.; Russell, R.G.; Pollard, J.W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 2001, 193, 727-740.
    • (2001) J. Exp. Med , vol.193 , pp. 727-740
    • Lin, E.Y.1    Nguyen, A.V.2    Russell, R.G.3    Pollard, J.W.4
  • 58
    • 0347123433 scopus 로고    scopus 로고
    • Tumour-educated macrophages promote tumour progression and metastasis
    • Pollard, J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 2004, 4, 71-78.
    • (2004) Nat. Rev. Cancer , vol.4 , pp. 71-78
    • Pollard, J.W.1
  • 60
    • 63149160727 scopus 로고    scopus 로고
    • Regulation of macrophage function in tumors: The multifaceted role of NF-kappaB
    • Hagemann, T.; Biswas, S.K.; Lawrence, T.; Sica, A.; Lewis, C.E. Regulation of macrophage function in tumors: The multifaceted role of NF-kappaB. Blood 2009, 113, 3139-3146.
    • (2009) Blood , vol.113 , pp. 3139-3146
    • Hagemann, T.1    Biswas, S.K.2    Lawrence, T.3    Sica, A.4    Lewis, C.E.5
  • 61
    • 77954563614 scopus 로고    scopus 로고
    • Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
    • DeNardo, D.G.; Andreu, P.; Coussens, L.M. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev. 2010, 29, 309-316.
    • (2010) Cancer Metastasis Rev , vol.29 , pp. 309-316
    • Denardo, D.G.1    Andreu, P.2    Coussens, L.M.3
  • 62
    • 0036839143 scopus 로고    scopus 로고
    • Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
    • Mantovani, A.; Sozzani, S.; Locati, M.; Allavena, P.; Sica, A. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23, 549-555.
    • (2002) Trends Immunol , vol.23 , pp. 549-555
    • Mantovani, A.1    Sozzani, S.2    Locati, M.3    Allavena, P.4    Sica, A.5
  • 63
    • 24944587964 scopus 로고    scopus 로고
    • Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors
    • de Palma, M.; Venneri, M.A.; Galli, R.; Sergi Sergi, L.; Politi, L.S.; Sampaolesi, M.; Naldini, L. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005, 8, 211-226.
    • (2005) Cancer Cell , vol.8 , pp. 211-226
    • de Palma, M.1    Venneri, M.A.2    Galli, R.3    Sergi Sergi, L.4    Politi, L.S.5    Sampaolesi, M.6    Naldini, L.7
  • 64
    • 79953750307 scopus 로고    scopus 로고
    • Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells
    • Mazzieri, R.; Pucci, F.; Moi, D.; Zonari, E.; Ranghetti, A.; Berti, A.; Politi, L.S.; Gentner, B.; Brown, J.L.; Naldini, L. et al. Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 2011, 19, 512-526.
    • (2011) Cancer Cell , vol.19 , pp. 512-526
    • Mazzieri, R.1    Pucci, F.2    Moi, D.3    Zonari, E.4    Ranghetti, A.5    Berti, A.6    Politi, L.S.7    Gentner, B.8    Brown, J.L.9    Naldini, L.10
  • 65
  • 67
    • 0033215242 scopus 로고    scopus 로고
    • Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
    • Olumi, A.F.; Grossfeld, G.D.; Hayward, S.W.; Carroll, P.R.; Tlsty, T.D.; Cunha, G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999, 59, 5002-5011.
    • (1999) Cancer Res , vol.59 , pp. 5002-5011
    • Olumi, A.F.1    Grossfeld, G.D.2    Hayward, S.W.3    Carroll, P.R.4    Tlsty, T.D.5    Cunha, G.R.6
  • 71
    • 38849202330 scopus 로고    scopus 로고
    • Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting
    • Pietras, K.; Pahler, J.; Bergers, G.; Hanahan, D. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med. 2008, 5, e19.
    • (2008) PLoS Med , vol.5
    • Pietras, K.1    Pahler, J.2    Bergers, G.3    Hanahan, D.4
  • 74
    • 6044270514 scopus 로고    scopus 로고
    • Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles
    • Nakagawa, H.; Liyanarachchi, S.; Davuluri, R.V.; Auer, H.; Martin, E.W.; de la Chapelle, A.; Frankel, W.L. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 2004, 23, 7366-7377.
    • (2004) Oncogene , vol.23 , pp. 7366-7377
    • Nakagawa, H.1    Liyanarachchi, S.2    Davuluri, R.V.3    Auer, H.4    Martin, E.W.5    de la Chapelle, A.6    Frankel, W.L.7
  • 76
    • 77950099096 scopus 로고    scopus 로고
    • Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast
    • Bauer, M.; Su, G.; Casper, C.; He, R.; Rehrauer, W.; Friedl, A. Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast. Oncogene 2010, 29, 1732-1740.
    • (2010) Oncogene , vol.29 , pp. 1732-1740
    • Bauer, M.1    Su, G.2    Casper, C.3    He, R.4    Rehrauer, W.5    Friedl, A.6
  • 77
    • 76349096670 scopus 로고    scopus 로고
    • Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner
    • Erez, N.; Truitt, M.; Olson, P.; Arron, S.T.; Hanahan, D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010, 17, 135-147.
    • (2010) Cancer Cell , vol.17 , pp. 135-147
    • Erez, N.1    Truitt, M.2    Olson, P.3    Arron, S.T.4    Hanahan, D.5
  • 80
    • 0033662405 scopus 로고    scopus 로고
    • + T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells
    • + T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity 2000, 12, 677-686.
    • (2000) Immunity , vol.12 , pp. 677-686
    • Qin, Z.1    Blankenstein, T.2
  • 81
    • 77954233120 scopus 로고    scopus 로고
    • Responsiveness of stromal fibroblasts to IFN-gamma blocks tumor growth via angiostasis
    • Lu, Y.; Yang, W.; Qin, C.; Zhang, L.; Deng, J.; Liu, S.; Qin, Z. Responsiveness of stromal fibroblasts to IFN-gamma blocks tumor growth via angiostasis. J. Immunol. 2009, 183, 6413-6421.
    • (2009) J. Immunol , vol.183 , pp. 6413-6421
    • Lu, Y.1    Yang, W.2    Qin, C.3    Zhang, L.4    Deng, J.5    Liu, S.6    Qin, Z.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.